Targovax to Present at Jefferies 2018 Global Healthcare Conference |
| June 04, 2018 | June 2018 Bond Updates |
|
OSLO, Norway, June 4, 2018 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company") (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that CMO Magnus Jäderberg will present a company overview at the Jefferies... |
| View more at: https://www.prnewswire.com/news-releases/targovax-to-present-at-jefferies-2018-global-healthcare-conference-300658868.html |
| Related News |
|